Earlier today, the Food and Drug Administration, along with the Centers for Disease Control and Prevention, announced that they were temporarily halting the use of the one-and-done Johnson & Johnson vaccine for the dreaded Wuhan virus.

As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare

— U.S. FDA (@US_FDA) April 13, 2021

CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.

— U.S. FDA (@US_FDA) April 13, 2021

Please join us via YouTube for an audio press conference at 10 a.m. EDT. We will keep the public updated as we learn more. https://t.co/fWguuQzhMR

— U.S. FDA (@US_FDA) April 13, 2021

The official announcement claims this suspension from use was the result of 6 blood clots out of nearly 7 million doses, but this explanation comes after several states had suspended the use of that vaccine over unspecified adverse events.

A coronavirus vaccine site in Georgia became the fourth US location this week to pause its administration of the Johnson & Johnson jab after concerns over possible adverse reactions, a report said.

…

The Johnson & Johnson vaccine was also halted in the past week at sites in Colorado, North Carolina and Iowa.

 

You may recall that the Johnson & Johnson vaccine trial was also briefly suspended due to adverse events.

Anyone who thinks this is just about 6 people getting blood clots is very ignorant or naive. States were shutting down vaccine sites last week from adverse reactions and rising reports of debilitating side effects in young people https://t.co/xo1g0qa1mS

— Julie Kelly 🇺🇸 (@julie_kelly2) April 13, 2021

No matter the reasoning, this is the last thing that a vaccination program that was already meeting substantial public resistance needs.